Indranil Nandi

Indranil Nandi has an extensive work experience in the pharmaceutical industry. Indranil currently holds the position of Senior Vice President and Chief Scientific Officer at Jubilant Radiopharma since January 2023. Prior to that, they worked at Jubilant Pharma where they served as the Chief Scientific Officer from August 2021 to February 2023, and as the Senior Vice President and Head of R&D from September 2019 to August 2021. Before joining Jubilant Pharma, Nandi worked as the Chief Scientific Officer at Vertice Pharma from February 2016 to September 2019. Indranil also held the position of Vice President R&D at Impax Laboratories from July 2014 to January 2016. Nandi has had previous roles at Sandoz Inc United States as the Executive Director of Portfolio Management and Scientific Affairs in 2014. Indranil also worked at Sandoz from 2009 to 2014, where they held various positions including Executive Director of Portfolio and Project Management, Director of Project Management, and Director of Development Operations. Their early experience in the industry includes working as a Senior Manager of Product Development at Par Pharmaceutical Inc from July 2006 to December 2008, and as a Senior Scientist at Sandoz from 2002 to 2006.

Indranil Nandi obtained an MBA degree from Rutgers University from 2005 to 2008. Prior to that, from 1997 to 2002, they pursued a PhD in Industrial Pharmacy at St. John's University.